Clinical Trial Update: TMC647055HPC1001 - First-in-human Trial to Examine Safety, Tolerability and Pharmacokinetics (How the Drug is Absorbed Into the Bloodstream) of Increasing Single Oral Doses and of Increasing Repeated Oral Doses of TMC647055 in Healthy Volunteers and in Hepatitis C Virus Infected Patients [Phase 1]

View source ↗

Summary

This is a first-in-human Phase 1 trial that assessed safety, tolerability, and pharmacokinetics of increasing single and repeated oral doses of TMC647055 in hea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• TMC647055

Snippet

Sponsor: Tibotec Pharmaceuticals, Ireland | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED